SCHEMBL7068358

SCHEMBL7068358

O=C(O)C1=C(Sc2ccc3c(c2)OCO3)c2ccccc2S(=O)(=O)N1Cc1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.43
RAB9A P51151 5/20 0.43
HSP90AA1 P07900 3/20 0.43
NPC1 O15118 3/20 0.43
PAX8 Q06710 2/20 0.43
TSHR P16473 2/20 0.42
EDNRA P25101 3/20 0.42
EDNRB P24530 2/20 0.42
XBP1 P17861 1/20 0.42
MAPT P10636 2/20 0.39
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
PKM P14618 1/20 0.37
KMT2A Q03164 1/20 0.37
SLC16A3 O15427 1/20 0.37
SLC16A1 P53985 1/20 0.37
KDM4E B2RXH2 2/20 0.36
RAF1 P04049 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070860 0.93 ALDH1A1 (0.44) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7068523 0.91 ALDH1A1 (0.48) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7071220 0.88 ALDH1A1 (0.54) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7826460 0.87 ALDH1A1 (0.40) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7068590 0.86 ALDH1A1 (0.51) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7069708 0.86 ALDH1A1 (0.51) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7066520 0.84 EDNRB (0.46) ALDH1A1L3MBTL1HTTRAB9ANPC1
SCHEMBL7069887 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7069102 0.83 EDNRA (0.47) ALDH1A1L3MBTL1HTTRAB9AHSP90AA1
SCHEMBL7069871 0.81 EDNRB (0.46) ALDH1A1L3MBTL1HTTEDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232787-A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic DOOLEY DAVID JAMES (US) 2003-12-18 US claimed
EP-0811001-B1 BENZOTHIAZINE DIOXIDES AS ENDOTHELIN ANTAGONISTS WARNER LAMBERT CO (US) 2001-10-31 EP claimed
US-20030232787-A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic DOOLEY DAVID JAMES (US) 2003-12-18 US disclosed
EP-0811001-B1 BENZOTHIAZINE DIOXIDES AS ENDOTHELIN ANTAGONISTS WARNER LAMBERT CO (US) 2001-10-31 EP disclosed
EP-0811001-A1 BENZOTHIAZINE DIOXIDES AS ENDOTHELIN ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-12-10 EP disclosed
WO-1996026195-A1 BENZOTHIAZINE DIOXIDES AS ENDOTHELIN ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1996-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232787-A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic EDNRA, EDNRB, ECE1 ALDH1A1 3140/4885L3MBTL1 4352/4885HTT 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.